Article
Communication With Clinicians and Relatives About Cascade Genetic Testing in Cancer Patients With Germline Pathogenic Variants.
JCO precision oncology - 1 Jun 2026
Kurian Allison W, Abrahamse Paul, Furgal Allison, Veenstra Christine M, Courser Rebecca R, Hofer Timothy P, Hodan Rachel, Caswell-Jin Jennifer L, Gomez Scarlett L, Ward Kevin C, Hamilton Ann S, Liu Lihua, An Lawrence C, Katz Steven J
Abstract excerpt
PURPOSE: Germline testing is underutilized and varies by cancer diagnosis. We hypothesized that patient and clinician involvement in cascade testing of relatives varies by the cancer susceptibility (breast v gastrointestinal [GI]) of the affected gene. METHODS: All patients diagnosed with cancer in Georgia or California during 2018-2019 and reported to SEER registries, who were linked to a pathogenic variant (PV)...
Topics
Join the communities discussing this publication.